Ganitumab

DB12205InvestigationalProtein Based Therapies

Ganitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.

Mechanism: Pharmacologically active on Insulin-like growth factor 1 receptor
Curator reviewed
Code names: AMG-479

Resolves to

Compound

UNIICK1441RCZ8CAS905703-97-1

Targets

P08069IGF1R

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

30Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ganitumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account